Recent FDA review process of inconclusive clinical studies creates a potentially unhealthy decision-making environment for patients needing gadolinium-enhanced MRIs.
Orest Boyko, MD, PhD
Advertisement
Articles by Orest Boyko, MD, PhD
Advertisement
Latest Updated Articles
U.S. Patients Left Fending For Themselves with Gadolinium Safety RisksPublished: December 11th 2017 | Updated:
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
New Imaging Platform Allows Single-Integration Access to Multiple AI Vendors
2
Is bpMRI Sufficient for Assessing PI-RADS 3 Lesions?
3
Can Contrast-Enhanced Mammography Offer a Viable Option for Pre-Op Assessment of Pathologic Nipple Involvement?
4
Fujifilm Sonosite Unveils Next-Generation Point-of-Care Ultrasound Device
5
